GCANRx is a clinical stage biopharmaceutical company focused on the development and commercialization of an innovative pharma-grade therapeutic that reduces disruptive symptoms in patients suffering from neuropsychiatric disorders without the side effects of existing medications.
GCANRx has teamed up with a world renowned research center to treat 100 children diagnosed with ASD and related behavioral problems, with a combination of CBD, and additional proprietary compounds for up to 24 weeks.
The purpose of the double-blind, placebo controlled study is to prove the efficacy of a new therapeutic in treating the core symptoms of Autism (ASD).
Company Details
- Founded
- -
- Address
- 15 Walker Ave, Baltimore,maryland,united States
- in****@****nrx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gcanrx.com
- HQ
- Baltimore, Maryland
Gcanrx Questions
Gcanrx's website is gcanrx.com
Gcanrx's LinkedIn profile is https://www.linkedin.com/company/gcanrx
Gcanrx's industry is
Biotechnology Research
Gcanrx's top competitors are
She Defined, Inc.,
Connexa Sports,
Patrick Duffy Group Ltd,
Textgrid,
Mediclic,
Siyata Mobile Inc,
Elegant Beginnings, Inc.,
Core Gaming, Inc.,
Plasmacure,
Samara Digital.
Gcanrx's support email address is info@gcanrx.com
Gcanrx's categories are Biotechnology Research
Gcanrx's founding year is 2018
